While ARK added new positions, the firm also trimmed several holdings. The largest sale involved Teradyne, a chip-testing equipment manufacturer. ARK sold 10,919 Teradyne shares through the ARK Innovation ETF. The transaction generated about $3.3 million. Teradyne shares fell 5.09% during the session.
Read More: Ark Invest Sees Crypto Market Hitting $28 Trillion by 2030: Here’s Why
The sale continues a recent pattern. ARK has reduced its Teradyne position across several days. The move reflects portfolio adjustments. The firm also sold shares of Ionis Pharmaceuticals. ARK sold 43,533 shares through its ARKG ETF. The transaction reached about $3.26 million.
Ionis shares dropped 3.28% that day. The sale follows a broader trend of ARK reducing exposure to the RNA-based drug developer. ARK trimmed two smaller holdings as well. The firm sold 18,392 shares of 10x Genomics. The transaction totaled roughly $376,000 across ARKK and ARKG.
Finally, ARK reduced its position in Circle Internet Group. The firm sold 11,194 shares through the ARK Innovation ETF. The sale reached about $1.26 million. Circle operates within blockchain payments and stablecoin infrastructure. The adjustment forms part of ARK’s broader portfolio rebalancing strategy.